BillionaireNet
Yancopoulos
George Yancopoulos
Rank #2207
UNITED STATESHealthcarePharmaceuticals

George Yancopoulos

Net Worth
$1.704B
-0.11% (24h)
George Yancopoulos, a Greek-American biomedical scientist, co-founded Regeneron Pharmaceuticals and currently serves as its President and Chief Scientific Officer. His source of wealth stems from his pioneering work in Pharmaceuticals. Yancopoulos has led the development of several FDA-approved drugs and holds over 100 patents, significantly contributing to the healthcare industry. His career is marked by remarkable achievements, including being the first R&D head in the pharmaceutical industry to become a billionaire. He is currently estimated to have a net worth of $1.8 billion.

The Full Dossier

Early Life

George D. Yancopoulos was born in 1959 to Greek immigrants and spent his early childhood in Woodside, New York. He attended New York City public schools and graduated as valedictorian from the Bronx High School of Science. As a student, he was a top winner of the Westinghouse Science Talent Search in 1976. Yancopoulos graduated as valedictorian from Columbia College and later received his M.D. and Ph.D. degrees from Columbia University's College of Physicians & Surgeons in 1987.

Rise to Success

Yancopoulos began his career in molecular immunology at Columbia University. In 1989, he co-founded Regeneron Pharmaceuticals with Leonard Schleifer. Under their leadership, Regeneron has become a leading biotechnology company, developing numerous FDA-approved medicines and innovative technologies. He was the 11th most cited scientist in the world during the 1990s.

Key Business Strategies

Yancopoulos's strategy has focused on scientific innovation and the development of cutting-edge technologies. Regeneron's success is built on its proprietary VelociSuite of technologies, which accelerate the development of human antibodies. He has overseen the invention of several FDA-approved drugs and has been instrumental in building a strong R&D culture at Regeneron.

Philanthropy

Yancopoulos is known for his philanthropic efforts, particularly in education and healthcare. He is actively involved in Regeneron's STEM Education commitments, leading the company to support science competitions, including the Regeneron Science Talent Search. He established the Yancopoulos Family Science Fellowship for Columbia College students.

Career Timeline

2020

Fortune's World's 25 Greatest Leaders

Recognized by Fortune as one of the World's 25 Greatest Leaders: Heroes of the Pandemic

2019

Alexander Hamilton Award

Received the Alexander Hamilton Award, Columbia's highest honor for contributions to science and medicine

2016

Ernst & Young Entrepreneur of the Year

Named Ernst & Young Entrepreneur of the Year along with Leonard Schleifer

2014

Inducted into the Biotech Hall of Fame

Inducted into the Biotech Hall of Fame

2004

Elected to the National Academy of Sciences

Elected to the National Academy of Sciences

1989

Co-founded Regeneron Pharmaceuticals

Co-founded Regeneron Pharmaceuticals with Leonard Schleifer

1987

MD, PhD from Columbia University

Received his M.D. and Ph.D. degrees from Columbia University's College of Physicians & Surgeons

1976

Westinghouse Science Talent Search Winner

Won the Westinghouse Science Talent Search while in high school

Philanthropic Impact

Education$100M+

Regeneron Science Talent Search

Supports the oldest and most prestigious high school science competition

EducationUnknown

Yancopoulos Family Science Fellowship

Established a fellowship for Columbia College students

Wealth Trajectory